JP2024502295A5 - - Google Patents

Info

Publication number
JP2024502295A5
JP2024502295A5 JP2023539028A JP2023539028A JP2024502295A5 JP 2024502295 A5 JP2024502295 A5 JP 2024502295A5 JP 2023539028 A JP2023539028 A JP 2023539028A JP 2023539028 A JP2023539028 A JP 2023539028A JP 2024502295 A5 JP2024502295 A5 JP 2024502295A5
Authority
JP
Japan
Prior art keywords
vector
cancer cells
electric field
pharmaceutical composition
alternating electric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023539028A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024502295A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/062198 external-priority patent/WO2022137171A2/en
Publication of JP2024502295A publication Critical patent/JP2024502295A/ja
Publication of JP2024502295A5 publication Critical patent/JP2024502295A5/ja
Pending legal-status Critical Current

Links

JP2023539028A 2020-12-24 2021-12-22 遺伝子治療において交流電場を使用するための方法及び組成物 Pending JP2024502295A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063130449P 2020-12-24 2020-12-24
US63/130,449 2020-12-24
PCT/IB2021/062198 WO2022137171A2 (en) 2020-12-24 2021-12-22 Methods and compositions for using alternating electric fields in gene therapy

Publications (2)

Publication Number Publication Date
JP2024502295A JP2024502295A (ja) 2024-01-18
JP2024502295A5 true JP2024502295A5 (cg-RX-API-DMAC7.html) 2025-01-07

Family

ID=80121763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023539028A Pending JP2024502295A (ja) 2020-12-24 2021-12-22 遺伝子治療において交流電場を使用するための方法及び組成物

Country Status (5)

Country Link
US (1) US20220203088A1 (cg-RX-API-DMAC7.html)
EP (1) EP4267236B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024502295A (cg-RX-API-DMAC7.html)
CN (1) CN116615268A (cg-RX-API-DMAC7.html)
WO (1) WO2022137171A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7886853B2 (ja) * 2020-09-18 2026-07-08 ノボキュア ゲーエムベーハー コロナウイルスを処置するための方法及び組成物
JP2025520663A (ja) * 2022-06-21 2025-07-03 ノボキュア ゲーエムベーハー 交流電場とcrispr-casシステムを用いた症状および疾患の治療システムおよび方法
CN115845254B (zh) * 2022-11-23 2024-02-02 湖南安泰康成生物科技有限公司 小细胞肺癌治疗系统以及交变电场发生装置

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980286A (en) 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
DE3681787D1 (de) 1985-07-05 1991-11-07 Whitehead Biomedical Inst Expression von fremdem genetischem material in epithelzellen.
DE68927996T2 (de) 1988-02-05 1997-12-04 Hughes Howard Med Inst Modifizierte hepatozyten und deren anwendung
WO1990002806A1 (en) 1988-09-01 1990-03-22 Whitehead Institute For Biomedical Research Recombinant retroviruses with amphotropic and ecotropic host ranges
US6261834B1 (en) 1991-11-08 2001-07-17 Research Corporation Technologies, Inc. Vector for gene therapy
WO1999011771A1 (en) * 1997-09-04 1999-03-11 Science Research Laboratory, Inc. Cell separation using electric fields
SE9704076D0 (sv) * 1997-11-06 1997-11-06 Holdingbolaget Vid Goeteborgs Method for permeabilisation of cell structures and use thereof
US7016725B2 (en) 2001-11-06 2006-03-21 Standen Ltd. Method and apparatus for destroying dividing cells
US8447395B2 (en) 2000-02-17 2013-05-21 Novocure Ltd Treating bacteria with electric fields
US20040092860A1 (en) * 2000-07-26 2004-05-13 Dev Nagendu B. Skin and muscle-targeted gene therapy by pulsed electrical field
WO2005115535A2 (en) 2004-04-23 2005-12-08 Novocure Ltd. Treating a tumor or the like with electric fields at different frequencies
CN102488967B (zh) * 2004-12-27 2016-03-30 诺沃库勒有限公司 利用电场从不同方向治疗肿瘤等
EP3143124B1 (en) * 2014-05-12 2025-01-22 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US20200308560A1 (en) * 2017-06-26 2020-10-01 The Broad Institute, Inc. Novel type vi crispr orthologs and systems
KR102793500B1 (ko) * 2018-05-02 2025-04-14 그랜드 디케이드 디벨로프먼츠 리미티드 전기천공 시스템, 방법, 및 장치
KR102870236B1 (ko) * 2018-07-03 2025-10-14 에드윈 창 세포막 투과성을 향상시키기 위한 교류 전기장 사용
WO2020047387A1 (en) * 2018-08-31 2020-03-05 Thomas Jefferson University In vivo genetic engineering of antigen responsive cells
CN113164525B (zh) * 2018-10-23 2025-03-14 利兰·斯坦福青年大学托管委员会 在基于干细胞的疗法中使用交变电场预防和治疗畸胎瘤形成

Similar Documents

Publication Publication Date Title
CN107075515B (zh) C/EBPα组合物和使用方法
Kretzmann et al. Tumour suppression by targeted intravenous non-viral CRISPRa using dendritic polymers
US20210206818A1 (en) Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof
Wang et al. A photoresponsive antibody–siRNA conjugate for activatable immunogene therapy of cancer
US20060211637A1 (en) Methods of down regulating target gene expression in vivo by introduction of interfering rna
Fujita et al. A novel platform to enable inhaled naked RNAi medicine for lung cancer
EP4317440A1 (en) Viral vector-based rna delivery system and use thereof
JP2008537752A (ja) がんおよび他の新血管形成疾患を処置するためのRNAi治療用の組成物および方法
Jia et al. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma
JP2021519296A5 (cg-RX-API-DMAC7.html)
CN107365785B (zh) 一种调控细胞内NF-κB活性的基因表达载体及其调控方法和应用
Yang et al. The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies
CN109563513B (zh) 一种抑制K-RAS基因表达的siRNA及其前体和应用
WO2017190695A1 (zh) 一种抑制EGFR基因表达的siRNA及其前体和应用
JP2024511525A (ja) Rnaプラスミド送達システム及びその使用
Takei et al. In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency
WO2019123414A1 (en) Engineered viruses expressing cyclic gmp-amp synthase
US20160220599A1 (en) Novel lincrna and interfering nucleic acid molecules, compositions and methods and uses thereof for regulating angiogenesis and related conditions
KR101286053B1 (ko) TGF-β1 발현을 억제하는 shRNA
CN120958133A (zh) 合成回路及其用途
Jesenko et al. Effective targeting of E2F1 transcription factor via siRNA gene electrotransfer in HT-29 colorectal carcinoma xenografts
JP2025516226A5 (cg-RX-API-DMAC7.html)
CN117257970A (zh) 靶向抑制表皮生长因子受体的递送系统及其在制备抗肿瘤产品中的应用
KR101374585B1 (ko) HSP27 발현을 억제하는 shRNA
JP2025504518A (ja) 改善された活性を有する修飾トランスファーrna